My NCBISign In
A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation
Susan D Mathias, James B Bussel, James N George, Robert McMillan, Gary J Okano, Janet L Nichol
Health Qual Life Outcomes. 2007; 5: 11. Published online 2007 February 22. doi: 10.1186/1477-7525-5-11
PMCID:
PMC1808052
Abstract Full Text PDF–264K

Is Cited by the Following 2 Articles in this Archive:

Patient-reported treatment burden of chronic immune thrombocytopenia therapies
T Michelle Brown, Ruslan V Horblyuk, Kelly M Grotzinger, Axel C Matzdorff, Chris L Pashos
BMC Blood Disord. 2012; 12: 2. Published online 2012 March 22. doi: 10.1186/1471-2326-12-2
PMCID:
PMC3350461
Abstract Full Text PDF–237K Supplementary Material
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective
Susan D Mathias, Sue K Gao, Kimberly L Miller, David Cella, Claire Snyder, Ralph Turner, Albert Wu, James B Bussel, James N George, Robert McMillan, Diane Kholos Wysocki, Janet L Nichol
Health Qual Life Outcomes. 2008; 6: 13. Published online 2008 February 8. doi: 10.1186/1477-7525-6-13
PMCID:
PMC2275726
Abstract Full Text PDF–354K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk